{"page_content": "ESG R eport 2022\nCorporate Headquarters\nAgios Pharmaceuticals, Inc.\n88 Sidney Street\nCambridge, MA 02139-4169\nwww.agios.com\nRyan, living with thalassemia\nMia, living with sickle cell disease", "metadata": {"source": "NASDAQ_AGIO_2021.pdf", "page": 42, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}